Search

everythinglearnresearchcommunity

for

Search:↓

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Some common medications can harm male fertility, but many effects can be reversed.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Some medications can cause acne, and stopping these drugs is the main treatment.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Methyl caprate greatly increases drug absorption through the skin and is better than other enhancers.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Menopause is a clear hormonal transition in women, while men experience a gradual testosterone decline, with some needing lifestyle changes and targeted therapy.